Registry for Hirschsprung Disease of the BELAPS
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Nov 5, 2020
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on Hirschsprung disease, a condition that affects the large intestine and can cause problems with bowel movements in children. The main goal of the study is to collect information about patients before, during, and after their surgery to help improve surgical care for children with this condition in Belgium. Researchers will look closely at how well children are able to use the bathroom 3.5 to 5.5 years after their surgery, as well as any long-term issues like constipation or incontinence.
To be part of this study, participants need to have been diagnosed with Hirschsprung disease and have undergone surgery for it. There are no specific exclusions mentioned, so most patients with this condition might be eligible. Those who join the trial can expect to provide information about their bowel habits and overall quality of life, which will help doctors understand how to better treat and support children with Hirschsprung disease in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hirschsprung Disease, surgery
- Exclusion Criteria:
- • -
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials